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Summary 
Gum kondagogu is a dried gum exudates obtained from the tree Cochlospermum gossypium 
and other species of Cochlospermum belonging to the family Bixaceae. It is a large, bushy 
deciduous tree that can grow up to 15 m high, which is grown in the forests of Andhra 
Pradesh, Madhya Pradesh and Rajasthan of India. This gum is an important non-wood forest 
natural product collected by tribals in the state of Andhra Pradesh and marketed by Girijan 
Cooperative Society, Andhra Pradesh, India. Experimental work carried out in our laboratory 
on this gum has resulted in assigning a separate identity to this gum as compared to the well 
established and commercially exploited gum karaya. Basically it is a polymer of rhamnose, 
galacturonic acid, glucuronic acid, b-D-galactopyranose, a-D-glucose, b-D-glucose, 
galactose, arabinose, mannose and fructose with sugar linkage of (1 →2) β -D-Gal p, (1→6)- 
β -D-Gal p,  (1 → 4) β-D-Glc p A, 4-0-Me- α -D-Glc p A,  (1 → 2) α-L-Rhap, with average 
molecular weight of 7.23 X10–6 g/mol determined by static light scattering method and Berry 
plots. GKG is composed of higher uronic acid content, protein, tannin, and soluble fibers. 
GKG was found to be safe in a 90-day sub chronic toxicity study conducted in rats. Gum 
kondagogu has unique physiochemical properties compared to other tree gums. Proximate 
analysis of the gum indicates that it has high volatile acidity and water-binding capacity. 
Eventhough, gum kondagogu is an important forest product, its commercial exploitation was 
limited due to non-availability of scientific information, especially in relation to its 
application in the pharmaceutical preparations. The overall objective of the present 
investigation was to evaluate the use of gum kondagogu in the pharmaceutical preparations 
as excipient. Based on the morphological, physico-chemical, structural and rheological, 
properties of gum kondagogu, present study explored the possibility of utilizing gum 
kondagogu as emulsifying agent, in the preparation of pH sensitive hydrogels for the 
controlled drug delivery and for the preparation of novel class of solid lipid nanoparticles 
referred as polymeric lipid nanoparticles. 
Chapter I, details the broad review of literature on various industrially important exudate 
gums with respect to the pharmaceutical applications. It also deals with the size and relative 
importance of the various players in the world market. The aim and scope of the 
experimental investigations were identified.  
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Chapter II deals the evaluation of gum kondagogu as an emulsifying agent for the 
preparation of biphasic liquid dosage form i.e emulsions. This chapter first describes the 
methods of preparation of emulsions using different concentrations of gum kondagogu as 
emulsifying agents. Liquid paraffin oil was used as oil phase at a concentration of 40% v/v 
according to the formulation for liquid paraffin oil emulsion mentioned in the B.P. The 
prepared emulsions with gum kondagogu as emulsifying agent were evaluated for 30 days 
stability studies by measuring stability on storage, change in particle size, change in apparent 
viscosity on storage and measuring the apparent rate of coalescence. Results showed that 
emulsion with gum kondagogu produced stable oil in water (o/w) type emulsions. 
Preliminary experiments revealed that emulsions prepared with >0.6% w/v gum kondagogu 
had a gel consistency, while those prepared with <0.1% w/v gum kondagogu were too dilute 
and separated within a few hours after preparation. Hence, the range of gum kondagogu 
concentrations for the preparation of liquid paraffin emulsions was chosen as 0.1–0.6% w/v. 
Particle size distribution studies were done on the emulsions prepared with different 
concentrations of gum kondagogu as emulsifying agent. Results indicated that emulsions 
displayed decrease in volume surface mean diameter, D [3, 2] values with increase in gum 
concentration. The apparent rate of coalescence (Kc day-1), calculated based on change in 
volume surface mean diameter, D [3, 2] on 30 days storage shows the values of 0.038, 0.007, 
0.005 and 0.005 for emulsions prepared with 0.1, 0.2, 0.4 and 0.6% w/v gum kondagogu 
respectively. Creaming is the process at which emulsion droplets separate from the 
continuous phase, flocculate and move towards the top or bottom, depending on the density 
difference between the continuous and dispersed phases. Creaming by itself not an indicative 
of emulsion break down, however it can also facilitate coalescence, which results in emulsion 
break down. Creaming studies revealed that emulsion prepared with 0.1 % was most 
susceptible to creaming (46.4 % ES) and emulsions prepared with 0.2, 0.4 and 0.6% w/v was 
least susceptible for creaming (70.4, 86.5 and 97.3 % ES respectively).  Apparent viscosities 
of aqueous emulsions prepared with different concentrations (0.1, 0.2, 0.4 and 0.6% w/v) was 
determined using rheometer, at a constant shear rate of 50 s−1 showed that with increase in 
concentration of gum increases the viscosity of emulsions. Effect on viscosity on storage of 
emulsions for 30 days shows there is no change in viscosity of the emulsions except for the 
emulsions prepared with 0.1% w/v gum kondagogu. These results clearly indicated that 
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emulsions prepared with 0.4 and 0.6% w/v gum kondagogu produced more stable emulsions 
by enhancing the viscosity of the continuous phase with less particle size by reducing the 
creaming and coalescence process. Flow properties were also determined by measuring 
viscosity at different shear rates from 1 to 100 s−1 at 250C and the data was fitted to power 
law equation. The emulsions prepared with gum kondagogu from 0.1 to 0.6% w/v shows the 
value less than 1 indicated that these emulsion exhibited pseudo plastic flow property.  
The second part of this chapter describes the mechanism of emulsifying properties of gum 
kondagogu. Surface, interfacial properties and zeta potential of the emulsions at different pH 
and ionic strength was measured to find the mechanism of emulsifying property of gum 
kondagogu. Gum kondagogu at concentrations of 0.1% w/v and 0.2% w/v displayed 
significantly (p<0.05), low surface/interfacial tensions between air/water or oil/water 
interfaces. However, increase in surface/interfacial tensions was observed at higher 
concentrations of 0.4% w/v and 0.6% w/v of gum kondagogu. The increase in 
surface/interfacial tension of GKG at higher concentrations may be attributed to gelation and 
high viscosity at higher concentrations. The surface activity of gum kondaggou is due to 
presence of high content of acetyl groups (-CO.OCH3), presence of high amount of fatty 
acids which imparts amphipathic character to the molecule. Further the zeta potential values 
dereased with increase in ionic strength. The decrease in zeta potential values in presence of 
NaCl can be attributed to compression of double layer formed around the oil droplets. The 
above results clearly indicated presence of residual protein also contributes the amphipathic 
behaviour of the gum kondagogu. Finally it was concluded that gum kondagogu produce oil 
in water emulsion with better emulsifying property at very low concentrations i.e at 0.4 -
0.6% w/v. Gum kondagogu stabilizes the emulsions mainly by two mechanisms (i) 
increasing the viscosity of the continuous phase (ii) producing mutual repulsion between oil 
droplets by adsorbing at oil/water interface. The surface activity of gum kondagogu is due to 
the presence of high acetyl content, presence of fatty acids and residual proteins present in 
the polymer. 
 
Chapter III describes the preparation and characterization of a novel hydrogel prepared 
from gum kondagogu (GKG) with chitosan (CS) by complex coacervation or polyelectrolyte 
complexation method. The first part of this chapter describes about the studies on the 
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complex formation between gum kondagogu and chitosan. Hydrogels have wide application 
in the drug delivery, protein immobilization, cell immobilization, enzyme immobilization, 
tissue engineering and wound dressing materials. Biocompatibility of this novel hydrogel 
(GKG-CS) was evaluated by both in vitro and in vivo studies. Complex formation between 
gum kondagogu and chitosan was determined by mixing the two polymers at different ratios 
and the resultant mixture was measured for zeta potential and viscosity of the polymers. Soft, 
insoluble hydrogel was obtained in the form of a white precipitate, after mixing the gum 
kondagogu with chitosan. The precipitated hydrogel was separated by centrifugation and the 
% yield of hydrogel was calculated.  Zeta potential values were changed from + ve charge to 
–ve charge, beyond the 80% w/w gum kondagogu in the mixture of gum kondagogu-chitosan 
mixture. Similarly, results of viscosity showed with reduction in the viscosity of the resulting 
supernatant after mixing the two polymers at 80% w/w gum kondagogu. These results 
indicated that the charge on the chitosan was neutralized with gum kondagogu at the ratio of 
4: 1 of GKG: CS.  The main factors effecting the complex coacervation process was pH and 
ionic strength.  Hence, effect of pH and ionic strength on the complex formation between the 
two polymers was studied. The complex formation between the two polymers was increased 
by increasing pH up to 5. The complex yield was gradually decreased above the pH value of 
5. The gum kondagogu solution transformed into ropy mucilage at alkaline pH, due to 
suppression of negative charges and agglomeration of colloid particles. The optimum pH for 
the complex formation between gum kondagogu and chitosan was found to be pH 5. 
Increasing amount of NaCl decreased the complex formation between the two polymers. This 
decrease in complex formation is due to screening of the charge groups on the 
polyelectrolytes by the ions.  
The cytotoxic effects of GKG-CS hydrogels (Direct contact asay), as well as their 
degradation products (in direct contact assay) at different concentrations were assessed on 
fibroblasts (fibroblast cell line L-929) using 3-(4,5-dimethylthiazole-2yl)-2,5-triphenyl 
tetrazolium, MTT assay). Macrophages are responsible for tissue repair through the release 
of several factors such as TNF- α and nitric oxide (NO).  Tumor necrosis factor-α (TNF- α) 
and nitric oxide (NO) production by macrophages (mouse macrophage cell line Raw 264.7)) 
were examined as indicators of cell activation. Fibroblast exposed to GKG-CS hydrogel 
particles and their degradation products showed less cytotoxic effect compared to chitosan 
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polymer alone measured by MTT test. TNF- α and nitric oxide production were dependent on 
GKG-CS hydrogel particles concentration. On direct exposure of GKG-CS hydrogel particles 
to macrophage cells, there was no significant (P > 0.05) elevation of nitrite and TNF- α levels 
at low concentrations (2.5 mg/ml) when, compared with the control cells. However, at higher 
concentration (10 mg/ml), there was a significant elevation of nitrite and TNF- α level. This 
study clearly demonstrated that macrophage incubation with GKG-CS hydrogel particles was 
activated to produce TNF- α and nitric oxide. 
 In vivo biocompatibility assessment was performed for 45 days. This study was performed 
using tablets obtained after compression of GKG-CS hydrogel particles implanted at the 
subcutaneous level in male Wistar rats. GKG-CS hydrogel biocompatibility and degradation 
were investigated using histopathology studies. Macrophages also play an important role in 
the phagocytosis of the material and its degradation in vivo. The inflammatory reaction is 
essential for preparing the wound for production of a new extracellular matrix. Cytokines and 
growth factors released by the inflammatory cells attract fibroblasts into the wound to initiate 
the reconstruction process. Histopathology of implanted site of GKG-CS hydrogel shows that 
prominent decrease in fibrous layer thickness, absence of necrosis, blood vessel formation 
indicated the good in vivo tolerance of the hydrogel. Accumulation of the macrophages and 
phagocytosis of the GKG-CS hydrogel particles might be lead to the entire resorption of the 
hydrogel. The accumulated macrophages also stimulates for release of TNF- α and nitric 
oxide and enhance the wound healing process which is evident from the cell activation 
studies using mouse macrophage cells. Based on its extreme hydrophilicity, high porosity 
allowing its invasion by phagocytic cells, and further resorption and clearance from the body, 
as well as its acceptable biocompatibility, GKG-CS hydrogel may constitute an appropriate 
candidate for a drug delivery vehicle. 
The second part of this chapter describes the utilization of the novel hydrogel prepared with 
gum kondagogu and chitosan (GKG-CS), as vehicle for the controlled rug delivery with 
diclofenac sodium. The rationale for the selection of diclofenac sodium as model drug is, 
because of the short biological half-life and associated gastric toxic effects. Preliminary study 
was done to find the maximum drug that can be loaded in to the hydrogels by adding 
different concentrations of diclofenac sodium to fixed amount of gum kondagogu–chitosan at 
a ratio 4:1. At a concentration of 0.2% w/v of diclofenac sodium, maximum entrapment 
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efficiency was obtained. Hence 0.2% w/v of diclofenac sodium was taken as final drug 
concentration for further studies. Hydrogels with different GKG/CS ratio (5:1, 3:1, 1:1 and 
1:3) were prepared with 0.2%w/v of diclofenac sodium by complex coacervation method. 
Particle size, flow properties and entrapment efficiency were measured for the hydrogels 
prepared with different GKG/CS ratio. The results showed that, with decrease in the 
concentration of gum kondagogu, particle size, entrapment efficiency and flow properties 
were decreased. The drug loaded hydrogels were characterized by using FTIR, TGA and 
SEM studies. FTIR and TGA study clearly shows that the interaction between the two 
polymers and interaction between drug-polymers is by electrostatic interaction. This 
electrostatic interaction is between amino group of chitosan and carboxyl group of gum 
kondagogu. There were no strong chemical interactions involved in the development of 
hydrogels between gum kondagogu and chitosan.  
Hydrogels prepared with different GKG/CS ratio were subjected to swelling studies in 
HCl/NaCl buffer of pH 1.2 followed by phosphate buffer pH 6.8 for calculating the % of 
swelling.  The difference in swelling of hydrogels in pH 1.2 and pH 6.8 could be explained 
on the basis of difference in the ionization and solubility of the polymers at different pH. It 
was found that, PEC-5:1 and PEC-3:1 showed less swelling when compared with PEC 1:3. 
This is due to the fact that, under acidic conditions, -COO- group of GKG gets protonated to 
form –COOH, which leads to decrease in the solubility of the polymer. Low swelling of 
PEC-5:1 and PEC-3:1 in acidic condition is due to less solubility of the GKG, where as PEC 
1:3 showed high swelling in acidic condition, because of more solubility of chitosan at this 
pH. At pH 6.8 buffer, PEC-5:1 and PEC-3:1 showed maximum swelling, as the –COOH 
group of GKG gets ionized to -COO- , which leads to increase in solubility of the polymer. 
Hence, PEC-5:1 and PEC-3:1 hydrogels absorbed more water, which led to increase in the 
swelling property at pH 6.8. In case of PEC-3:1, which contain high proportion of CS, there 
was no swelling, because CS is unionized at pH 6.8 and also CS was insoluble at this pH. In 
vitro drug release study shows that, diclofenac loaded hydrogels release more drug in pH 6.8 
buffer compared to that of pH 1.2 buffer. This was due to pH sensitive response of the 
hydrogels. With increase in gum kondagogu (% w/w) concentration in the hydrogels, the 
release of diclofenac sodium was observed to be enhanced as GKG is a hydrophilic polymer, 
can promote the entry of solution into the particles causing maximum swelling and there is a 
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mutual repulsion between carboxylate ions of diclofenac sodium and GKG. It was also found 
that PEC-5:1 and PEC-3:1 released the drug in controlled manner upto 10h. The release 
profile of drug from hydrogels with different GKG/CS ratios were subjected to zero order, 
first order, Higuchi diffusion equations. It was found that the in vitro drug release from 
hydrogels was best explained by Higuchi’s equation as the plots showed highest linearity (r2 
>0.9) followed by zero order indicating that the concentration was nearly independent of 
drug release. To find out the release mechanism, the corresponding plot (log cumulative 
percent drug release vs time) for Krosmeyer peppa’s   equation indicated a good linearity (r2 
> 0.9) and the release exponent ‘n’ for PEC-5:1 and PEC-3:1 hydrogels was in between 0.5 
and 0.8 indicating combined of diffusion and erosion mechanism, so called anomalous (non-
Fickian) diffusion which indicated the drug release is controlled by more than one process. 
The causes for diffusion may be due to the swollen insoluble hydrogel matrix, which 
entrapped the drug. The cause for good correlation for erosion may be due to the presence of 
the surface drug and due to the break down of the swollen matrix to smaller sizes. 
Further, diclofenac loaded hydrogels (PEC-5:1 and PEC 3:1) were subjected to 
pharmacokinetics and pharmacodynamic studies. Effect of diclofenac loaded hydrogels on 
pharmacokinetic parameters were evaluated in Wistar rats by administering the diclofenac 
sodium equivalent to 15 mg/kg per orally and the plasma drug concentrations were measured 
by using HPLC. Diclofenac sodium concentrations in the plasma were significantly (p < 
0.05) altered at all the time points except at 2h after entrapping the diclofenac sodium in the 
hydrogels when compared to those of pure diclofenac sodium. The plasma AUC 0-α values 
for diclofenac sodium released from PEC 5:1(96.67 ± 12.8 µg.ml-1.h) and from PEC-3:1 
hydrogels (96.67 ± 12.88 µg.h.ml-1 ) were 3.2 and 2.9 folds greater than pure diclofenac 
sodium (29.8 ± 2.7 µg.ml-1.h.) respectively The elimination half-lives (t1/2) were 1.69 ± 0.27, 
3.81 ± 0.4 and 4.60 ± 0.94 h for pure diclofenac sodium, PEC-5:1 & PEC-3:1 hydrogels 
respectively. These results indicates, 2.2 and 2.7 fold increase in elimination half-life of the 
diclofenac sodium entrapped in PEC-5:1 and PEC-3:1respectively, when compared with the 
pure diclofenac sodium (P<0.05) which indicates the prolonged release of the drug. 
Pharmacodynamic studies for drug loaded hydrogels were also studied by using carrageenan 
induced paw edema model, by administering the hydrogels (p.o) at dose of 15 mg/kg body 
weight. The carrageenan treated animals showed significant increase in paw volume 
 202
Chapter-5                                                                      Summary and Conclusion 
compared to the normal paw (p< 0.05). Rats administered with pure diclofenac sodium, PEC-
5:1 and PEC-3:1 hydrogels showed significant inhibition of % of swelling (p<0.05), when 
compared with the control group. Pure diclofenac sodium, showed maximum % of inhibition 
at 3rd h and the % inhibition was found to decrease with the time. But in case of PEC-5:1 and 
PEC-3:1, the anti-inflammatory activity of diclofenac sodium was 61% at the end of the 4 h, 
which was maintained almost up to 8 h (59% & 58% respectively). These data clearly 
indicated the controlled and uniform release of diclofenac sodium from diclofenac loaded 
hydrogels. In vivo gastrointestinal tolerance of diclofenac loaded hydrogels were evaluated 
by giving, diclofenac loaded hydrogels at a dose of 15 mg kg-1, (p.o) for 7 consecutive days 
by comparing the results with that of pure diclofenac sodium. Results indicated the low 
gastric toxicity of drug released from the hydrogels compared to pure diclofenac sodium. 
In conclusion the present investigation proved that the novel hydrogel prepared from gum 
kondagogu/chitosan (GKG-CS) holds a great potential as a natural polymer based delivery 
device for controlled delivery of diclofenac sodium for two reasons: (i) to reduce dosing 
frequency and (ii) lower the gastric toxicity. Good In vitro and in vivo biocompatibility of 
hydrogels also forms the basis for the future research for the use of these novel hydrogels as 
implants, scaffolds, as an encapsulating material for proteins, cells and enzymes. 
 
Chapter 1V presents the development and characterization of novel polymeric lipid 
nanoparticle (PLN) systems, which used an anionic polymer, gum kondagogu to improve the 
water soluble drug doxorubicin hydrochloride into the lipid. PLN incorporate many of the 
key features of ionic polymers and lipids, in which lipid provide ease of fabrication of 
nanoparticles and hydrophobicity for slow drug release and polyanionic polymer enables 
loading of doxorubicin in the lipid based carrier and allows some extent of control drug 
release. This chapter first describes the partition coefficient experiment of doxorubicin 
hydrochloride which gives the idea, whether the utilization of gum kondagogu enhanced the 
partition of the doxorubicin hydrochloride in the lipid or not. Because the major limitation 
for the solid lipid nanoparticles is low entrapment efficiency for water soluble drugs like 
doxorubicin hydrochloride due to low partition in the lipid. It was found that addition of 
GKG to doxorubicin solution showed the increase in percentage of doxorubicin partitioned in 
the lipid phase from 47.4 ± 2.5 to 88.3 ± 5.2 (% w/w). Efficiency of drug-polymer binding 
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determines the amount of polymer needed for optimal drug loading was evaluated by 
measuring the entrapment efficiency of the doxorubicin after adding to the different 
concentration of gum kondagogu solution. It was found that at 2:1 ratio of gum kondagogu: 
doxorubicin resulted in more entrapment efficiency. Complexation between the polymer and 
doxorubicin was characterized by visible and fluorescence spectrophotometry which revealed  
the stacking interaction of doxorubicin molecules immobilized along gum kondagogu chains. 
As the prepared drug-polymer complex is prone to aggregation, it was incorporated into the 
lipid in the form of PLN using micro emulsion technique with Tween-80 as surfactant and 
glyceryl mono stearate as the lipid phase. The new nanoparticle drug carrier was typically in 
the range of 132-405 nm in diameter. High drug loading capacity was achieved for the 
doxorubicin loaded PLN in presence of gum kondagogu, when compared to that of 
doxorubicin loaded lipid nanoparticles with out polymer. The comparison of zeta potential 
between blank PLN and drug loaded PLN demonstrated the neutralization of charge in the 
drug -polymer complex. FTIR spectra data showed that absence of chemical interaction 
between the drug and the excipients. In vitro drug release study of doxorubicin from 
doxorubicin-gum kondagogu complex showed higher release in 0.05M CaCl2, than in the 
water indicating that drug was released by ion exchange process. Under physiological 
condition, GKG-doxo complex released more drug when compared to that of doxorubicin 
loaded PLN. Without lipid barrier, the drug molecules that are bound to surface of the 
polymer aggregates by ionic complexation can be rapidly released in the presence of counter 
ions in the buffer. In case of PLN, lipid acts as a barrier and retard rapid release of the drug in 
presence of counter ions. This finding once again confirms the importance of the lipid in the 
formulation.  
The efficacy of newly developed doxorubicin loaded PLN was evaluated by measuring 
cytotoxicity in B16F10 (mouse melanoma), A549 (Lung cancer) and MDA-MB (Breast 
cancer), cells by using MTT method and the results were compared with the cytotoxicity of 
doxorubicin solution. It was found that cytotoxicity for doxorubicin loaded PLN was 
enhanced when compared with doxorubicin solution. The enhanced cytotoxicity for PLN is 
due to increase in intra cellular distribution of the drug. Further studies were done to evaluate 
the mechanism of drug uptake for the PLN by the cells, in which the cells were exposed with 
colchicine (pinocytic inhibitor) and cytochalasin (Phagocytosis inhibitor) prior to drug 
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treatment. It was found that cells pre-exposed with cytochalasin showed more inhibition for 
drug uptake indicates that, PLN enters in to the cells by endocytosis process. Effect of 
doxorubicin loaded PLN on pharmacokinetic parameters were evaluated in C57BL/6 mice by 
administering the doxorubicin equivalent to 10 mg/kg intra peritoneal route. The plasma and 
tissue drug concentration was measured by using HPLC. The doxorubicin loaded PLN 
altered pharmacokinetics parameters with increase in AUC 0-α and t1/2 for 3.1 and 4.8 folds 
respectively when compared with doxorubicin solution. The distribution of doxorubicin in 
the heart of mice treated with drug loaded PLN showed decreased in distribution by1.5 folds 
compared to that of doxorubicin solution. The major side effect of doxorubicin is considered 
as cardiac toxicity and hence, these results show another advantage of DX-PLN which may 
decrease the cardiac toxicity induced by the doxorubicin solution. In vivo efficacy study of 
doxorubicin loaded PLN was studied in B16F10 cells induced tumors in C57BL/6 mice. 
Unlike human cell lines, which require imuno-compromised mice to grow properly with out 
eliciting rejection by the host immune response, B16F10 cells derived from C57BL/6 mice 
were used for the induction of the tumor. Doxorubicin incorporated in the PLN, significantly 
enhanced the therapeutic activity when compared with control group. However, therapeutic 
efficacy was not significant (p>0.05) when compared to doxorubicin solution treated, tumor 
bearing mice. However, it tremendously decreased the toxicity induced by the doxorubicin 
solution alone and increased the mean survival time of the mice. The present investigation 
suggests that doxorubicin incorporated polymeric lipid nanoparticles (PLN) had higher drug 
entrapment efficiency for water soluble drug doxorubicin hydrochloride which is one of the 
major limitation for the conventional lipid nanoparticles. This novel PLN carrier for 
doxorubicin also improved the pharmacokinetics and biodistribution of the doxorubicin and 
reduced the toxicity produced by the conventional doxorubicin solution.  
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Overall conclusion 
Gum kondagogu is an important non-wood forest natural product collected by tribals in the 
state of Andhra Pradesh and marketed by Girijan Cooperative Society, Andhra Pradesh, 
India. Experimental work carried out in our laboratory on this gum has resulted in assigning a 
separate identity to this gum as compared to the well established and commercially exploited 
such as gum Arabic, gum tragacanth and gum karaya. The experimental methods and 
analytical data obtained, which may immensely contribute to explore gum kondagogu as an 
important tree exudates gum in the world market and give a value added product to our 
nation, especially for its potential application in pharmaceutical industry. 
Limitations and Future Plans of the Thesis 
Although substantial work has been done in the thesis for the rational use of gum kondagogu 
in the pharmaceutical preparations, some limitations have been identified due to constraints 
in time, availability of experimental conditions and equipment. Several questions remain to 
be answered regarding the utilization aspect of gum kondagogu in the pharmaceutical 
preparations. The following are the some limitations from the thesis which need to be 
explored 
 
¾ The prepared emulsions with gum kondagogu for liquid paraffin oil emulsions at 40% 
v/v concentration were found to be producing stable emulsions. But the stability of 
the emulsions is also dependent up on the concentration of the oil phase and type of 
the oily phase, which needs further exploration. In addition utilization of gum 
kondagogu as emulsifying agent for the delivery of oil soluble drugs like griseofulvin, 
oil soluble vitamins like Vitamin-A, Vitamin –D and Viatmin –E in the form of 
emulsions need to be explored 
¾ Studies are needed to evaluate the utilization of novel hydrogel (GKG-CS) for the 
delivery of drugs other than diclofenac sodium, which need to be released at the 
specific site such as colon region. Further studies are required for the application 
hydrogel prepared with gum kondagogu for the encapsulation of proteins, probiotic 
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bacteria, immobilization of enzymes, as scaffolds in tissue engineering and in the 
preparation of wound dressings.  
¾ In the preparation of polymeric lipid nanoparticles (PLN), glyceryl mono stearate 
alone was studied as lipid phase and Tween-80 as surfactant. Studies are needed to 
explore other lipid and surfactants for the preparation of PLN for improving the 
efficacy of the doxorubicin hydrochloride. Further studies are also needed for the 
surface modification of lipid or the polymer for ligand specific targeting which may 
enhance the therapeutic efficacy of the doxorubicin.  
 
 
